Barriers to and Facilitators of Implementing Guidelines for Detecting Familial Hypercholesterolaemia in Australia
Mitchell Sarkies(Macquarie University), Gerald F. Watts(Royal Perth Hospital), Warrick Bishop, Jing Pang(The University of Western Australia), David L. Hare(The University of Melbourne), Karam Kostner(Mater Health Services), Karen Hutchinson(Macquarie University), Walter P. Abhayaratna(Australian National University), Ari Horton(Monash Children’s Hospital), Stephen J. Nicholls(Australian Centre for Heart Health), David Sullivan(Royal Prince Alfred Hospital), Tom Brett(The University of Notre Dame Australia), Stephanie Best(The University of Melbourne), Jeffrey Braithwaite(Macquarie University), Peter Clifton(Royal Adelaide Hospital), Joanna C. Moullin(Curtin University), Nadarajah Kangaharan, Andrew Black(Royal Hobart Hospital), Luke Testa(Macquarie University)
Cited by 16
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
|New England Journal of Medicine|2012|2k